Beam Therapeutics

+$0.94 (+2.26%) Today
+$0.49 (+1.15%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BEAM and other ETFs, options, and stocks.

About BEAM

Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing.

CEO
John Evans
Employees
341
Headquarters
Cambridge, Massachusetts
Founded
2017

BEAM Key Statistics

Market cap
2.99B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.86M
High today
$43.83
Low today
$39.73
Open price
$41.95
Volume
2.78M
52 Week high
$138.52
52 Week low
$27.77

BEAM Earnings

-$3.35
-$2.23
-$1.12
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure